Rapidly growing biotech business, Aptamer Group Ltd, has closed its Series A investment round after attracting international interest, securing $2.2m of funding from overseas investors …

Company will spend $600 million on emerging/growth enterprises, with a focus on neuroscience. Pfizer Ventures, the venture capital arm of Pfizer, Inc, was founded in …

WuXi Biologics will invest €325m in company’s first site outside of China A major Chinese biopharmaceutical company is to create 400 jobs with a €325 …

Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach ADC Biotechnology (ADC Bio), announces that it has secured £1.14 million in …